Lazard Asset Management LLC Pacific Biosciences Of California, Inc. Transaction History

Lazard Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$9.97 - $14.05 $568 - $800	57 Added 1.63%	3,549 $47,000
Q1 2023 May 15, 2023	BUY	$7.94 - $12.02 $27,726 - $41,973	3,492 New	3,492 $40,000
Q4 2020 Feb 11, 2021	SELL	$10.5 - $28.5 $83,107 - $225,577	-7,915 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$3.61 - $9.87 $8,057 - $22,029	-2,232 Reduced 22.0%	7,915 $78,000
Q2 2020 Aug 13, 2020	BUY	$2.65 - $4.03 $8,472 - $12,883	3,197 Added 46.0%	10,147 $35,000
Q1 2020 May 14, 2020	BUY	$2.36 - $5.26 $16,402 - $36,557	6,950 New	6,950 $21,000

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.